» Authors » C H Hoke Jr

C H Hoke Jr

Explore the profile of C H Hoke Jr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 518
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanesa-thasan N, Edelman R, Tacket C, Wasserman S, Vaughn D, Coster T, et al.
Am J Trop Med Hyg . 2004 Jan; 69(6 Suppl):17-23. PMID: 14740951
We describe the results of initial safety testing of 10 live-attenuated dengue virus (DENV) vaccine candidates modified by serial passage in primary dog kidney (PDK) cells at the Walter Reed...
2.
Kanesa-thasan N, Sun W, Van Albert S, Putnak J, King A, Raengsakulsrach B, et al.
Vaccine . 2001 Apr; 19(23-24):3179-88. PMID: 11312014
A randomized, controlled, double-blinded study was conducted to determine safety and immunogenicity of five live attenuated dengue vaccines produced by Aventis Pasteur (AvP). The study was completed with 40 flavivirus...
3.
Raengsakulrach B, Nisalak A, Gettayacamin M, Thirawuth V, Young G, Myint K, et al.
Am J Trop Med Hyg . 1999 Aug; 60(3):343-9. PMID: 10466959
Two poxvirus-vectored vaccines for Japanese encephalitis (JE), NYVAC-JEV and ALVAC-JEV, were evaluated in rhesus monkeys for safety, immunogenicity, and protective efficacy. The vaccines were given to four monkeys each on...
4.
Myint K, Raengsakulrach B, Young G, Gettayacamin M, Ferguson L, Innis B, et al.
Am J Trop Med Hyg . 1999 Aug; 60(3):338-42. PMID: 10466958
Twelve rhesus macaques (Macaca mulatta) challenged intranasally with a wild-type Japanese encephalitis virus (JEV) developed clinical signs 11-14 days later. Tissues from the cerebral cortex, cerebellum, brainstem, thalamus, meninges, and...
5.
Raengsakulrach B, Nisalak A, Gettayacamin M, Thirawuth V, Young G, Myint K, et al.
Am J Trop Med Hyg . 1999 Aug; 60(3):329-37. PMID: 10466957
Placebo-controlled field efficacy trials of new Japanese encephalitis (JE) vaccines may be impractical. Therefore, an animal model to evaluate efficacy of candidate JE vaccines is sought. Previous work has shown...
6.
DeFraites R, Gambel J, Hoke Jr C, Sanchez J, Withers B, KARABATSOS N, et al.
Am J Trop Med Hyg . 1999 Aug; 61(2):288-93. PMID: 10463681
The safety and immunogenicity of Japanese encephalitis (JE) vaccine (Nakayama strain, monovalent / BIKEN) was studied in 538 U.S. soldiers in 1990. Three doses of vaccine from three consecutively manufactured...
7.
Konishi E, Kurane I, Mason P, Shope R, Kanesa-thasan N, Smucny J, et al.
Vaccine . 1998 Jun; 16(8):842-9. PMID: 9627942
Poxvirus-based recombinant Japanese encephalitis (JE) vaccine candidates, NYVAC-JEV and ALVAC-JEV, were examined for their ability to induce JE virus-specific cytotoxic T lymphocytes (CTLs) in a phase I clinical trial. These...
8.
Kanesa-thasan N, Chang G, Smoak B, Magill A, BURROUS M, Hoke Jr C
Emerg Infect Dis . 1998 Jun; 4(2):299-303. PMID: 9621203
Nucleotide sequence analysis was performed on 14 dengue virus isolates (13 dengue-2 viruses and 1 dengue-3 virus) recovered from febrile soldiers in Somalia in 1993. The dengue-2 viruses were most...
9.
Gambel J, Shlim D, Canas L, Cox N, Regnery H, Scott R, et al.
Emerg Infect Dis . 1998 Mar; 4(1):128-30. PMID: 9452409
No abstract available.
10.
Gouvea V, Hoke Jr C, Innis B
J Virol Methods . 1998 Mar; 70(1):71-8. PMID: 9506814
The genomic variability of hepatitis E virus (HEV) was examined by restriction endonuclease analysis (REA) of four genomic cDNA copies comprising a 499 bp segment of the putative polymerase gene,...